Propeller Health, a Madison, Wisconsin-based provider of digital solutions for respiratory medicine has received FDA 510(k) clearance to market its digital sensor for use with GSK’s Ellipta® patented, dry powder inhaler. The custom sensor designed exclusively for the Ellipta inhaler was cleared as part of a R&D collaboration between Propeller and GSK announced in late 2015.For the R&D collaboration, the Propeller sensor automatically collected and recorded data on the Ellipta inhaler's
Read More
Propeller Health | COPD | News, Analysis, Insights
Propeller Health Lands $21.5M to Modernize Respiratory Disease Management
Propeller Health, a digital solution for respiratory medicine has raised $21.5 million in Series C funding from 3M Ventures, S.R. One, Limited, Hikma Ventures and existing investors Safeguard Scientifics and Social Capital. The round also includes participation from existing investors Safeguard Scientifics and Social Capital. The company plans to utilize the funding to expand Propeller’s FDA-cleared digitally-guided therapy platform. Despite an abundance of effective medications, the burden of
Read More
Propeller, Health Vectura Partner To Develop Connected Dry-Powder Inhaler
Digital health company Propeller Health is teaming up with respiratory pharmaceutical company Vectura to develop digitally connected dry powder inhaler (“DPI”) technology inhalers integrated with Propeller's FDA-cleared digital health platform. The partnership will bring a new connected dry-powder inhaler device onto the Propeller platform. Vectura provides a range of pre-metered foil blister-based dry powder inhalers developed to meet patients’ needs in inhalation therapy. The initial focus of
Read More
Propeller Health, Aptar Partner To Develop Connected Metered Dose Inhaler
Digital health company Propeller Health is teaming up with Aptar Pharma (Aptar) to develop the world's first integrated connected metered dose inhaler (cMDI), with an integrated sensor and a novel electronic dose counter. The device is currently available for licensing and is expected to enter clinical studies later this year.
Connected Metered Dose Inhaler Development Details
Pressurized MDIs are the most common type of inhaler device on the market today, with over 600 million units
Read More
Humana Joins Sensor, Big Data-Driven Collaboration to Reduce Asthma in Louisville
Humana is the latest local employer to join AIR Louisville, a new approach to improving asthma that leverages sensors, big data, and community collaboration.
AIR Louisville is a grant-funded program designed to reduce the burden of asthma inLouisville, Kentucky, a city consistently ranked as one of the most challenging in the US for people with asthma. The program aligns to Humana's local strategy to address respiratory illness among its employees and members.
Dr. Rae Godsey, DO, the
Read More
Propeller Health, GSK to Develop Digital Sensor for Ellipta® Inhaler
Propeller Health, provider of an FDA-cleared digital health solution for improving outcomes in asthma and chronic obstructive pulmonary disease (COPD), today announced its first development and R&D collaboration agreement with GSK for development of a custom medication sensor for GSK’s Ellipta inhaler. This deal continues an accelerating trend of pharmaceutical companies working to connect respiratory medications via sensors and services to improve the use of these medications and outcomes
Read More
FDA Clears 2 Propeller Health Inhaler Devices for Asthma, COPD
Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced U.S. Food and Drug Administration 510(k) clearance to market its Propeller platform in association with medications using GlaxoSmithKline’s Diskus® dry powder inhaler (DPI) device for asthma and chronic obstructive pulmonary disease (COPD). This new clearance follows 510(k) clearance to market the Propeller platform in association with medications using Boehringer Ingelheim’s Respimat®
Read More
Propeller Health Gains FDA Clearance for New Propeller Sensor
Propeller Health, the mobile platform provider of respiratory health management, today announced U.S. Food and Drug Administration 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor.
Read More
